drugset / Trial / NCT03154840
Relative Bioavailability Among Different Eutropin Formulations
RandomizedCrossoverOpen-labelHealth-services research
Summary
1. Compares and evaluates the relative bioavailability of single-dose subcutaneous administration of each of the Eutropin formulations to healthy male volunteers. 2. Ensure safety and tolerability of single, subcutaneous administration of Eutropin formulations to healthy male volunteers.
Timeline
- Start
- 2017-05-31
- Primary completion
- 2017-07-10
- Completion
- 2017-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eutropin | Protein / enzyme biologic | 4 iu | Subcutaneous |
| Subject | Eutropin | Protein / enzyme biologic | 12 iu | Subcutaneous |
| Subject | Eutropin | Protein / enzyme biologic | 36 iu | Subcutaneous |
Indications
No indication recorded.